These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31432599)

  • 1. An empirical assessment of immeasurable time bias in the setting of nested case-control studies: Statins and all-cause mortality among patients with heart failure.
    Oh IS; Filion KB; Jeong HE; Shin JY
    Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1318-1327. PubMed ID: 31432599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical approaches to minimizing immeasurable time bias in cohort studies.
    Oh IS; Baek YH; Jeong HE; Filion KB; Shin JY
    Int J Epidemiol; 2021 Jul; 50(3):987-999. PubMed ID: 33367629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New methodological approaches were able to effectively reduce immeasurable time bias in case-only designs.
    Jeong HE; Oh IS; Lee H; Filion KB; Shin JY
    J Clin Epidemiol; 2021 Mar; 131():1-10. PubMed ID: 33171274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating an approach to overcome the immeasurable time bias in cohort studies: a real-world example and Monte Carlo simulation study.
    Oh IS; Jeong HE; Lee H; Filion KB; Noh Y; Shin JY
    Int J Epidemiol; 2023 Oct; 52(5):1534-1544. PubMed ID: 37172269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies?
    Palmaro A; Boucherie Q; Dupouy J; Micallef J; Lapeyre-Mestre M
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):544-553. PubMed ID: 28266748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immeasurable Time Bias in Self-controlled Designs: Case-crossover, Case-time-control, and Case-case-time-control Analyses.
    Jeong HE; Lee H; Oh IS; Filion KB; Shin JY
    J Epidemiol; 2023 Feb; 33(2):82-90. PubMed ID: 34053964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Statins to Reduce All-Cause Mortality in Heart Failure Patients: Findings from the EPICAL2 Cohort Study.
    Al-Gobari M; Agrinier N; Soudant M; Burnand B; Thilly N
    Am J Cardiovasc Drugs; 2019 Oct; 19(5):497-508. PubMed ID: 30972619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration.
    Patrick AR; Schneeweiss S; Brookhart MA; Glynn RJ; Rothman KJ; Avorn J; Stürmer T
    Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):551-9. PubMed ID: 21394812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results.
    Schneeweiss S; Patrick AR; Stürmer T; Brookhart MA; Avorn J; Maclure M; Rothman KJ; Glynn RJ
    Med Care; 2007 Oct; 45(10 Supl 2):S131-42. PubMed ID: 17909372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical Approaches to Reduce Selection Bias in As-Treated Analyses with Missing In-Hospital Drug Information.
    Baek YH; Noh Y; Oh IS; Jeong HE; Filion KB; Lee H; Shin JY
    Drug Saf; 2022 Oct; 45(10):1057-1067. PubMed ID: 35978219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immeasurable time bias in observational studies of drug effects on mortality.
    Suissa S
    Am J Epidemiol; 2008 Aug; 168(3):329-35. PubMed ID: 18515793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.
    Krum H; Bailey M; Meyer W; Verkenne P; Dargie H; Lechat P; Anker S
    Cardiology; 2007; 108(1):28-34. PubMed ID: 16960445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Effects of Statin Use on Mortality in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
    Lee MS; Duan L; Clare R; Hekimian A; Spencer H; Chen W
    Am J Cardiol; 2018 Aug; 122(3):405-412. PubMed ID: 30201108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy and risks for death and hospitalization in chronic heart failure.
    Go AS; Lee WY; Yang J; Lo JC; Gurwitz JH
    JAMA; 2006 Nov; 296(17):2105-11. PubMed ID: 17077375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying bias reduction with fixed-duration versus all-available covariate assessment periods.
    Connolly JG; Schneeweiss S; Glynn RJ; Gagne JJ
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):665-670. PubMed ID: 30786103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use and survival outcomes in elderly patients with heart failure.
    Ray JG; Gong Y; Sykora K; Tu JV
    Arch Intern Med; 2005 Jan; 165(1):62-7. PubMed ID: 15642876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Different Case-Crossover Variants in Handling Exposure-Time Trend or Persistent-User Bias: Using Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure as an Example.
    Dong YH; Wang SV; Gagne JJ; Wu LC; Chang CH
    Value Health; 2020 Feb; 23(2):217-226. PubMed ID: 32113627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable effects of statins in the treatment of heart failure with preserved ejection fraction in patients without ischemic heart disease.
    Tsujimoto T; Kajio H
    Int J Cardiol; 2018 Mar; 255():111-117. PubMed ID: 29307549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R; Wang Y; Foody JM
    Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study.
    Nguyen T; Duan Z; Naik AD; Kramer JR; El-Serag HB
    Gastroenterology; 2015 Nov; 149(6):1392-8. PubMed ID: 26208896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.